Sectors
XBIT
XBiotech Inc.
2.28
2 x 1.62
2 x 2.91
bid
ask
+
0.01
0.44%
02:08 PM
timesize
| Ytd | -4.60% | |
| 1y | -27.85% |
2.25
day range
2.28
2.09
52 week range
3.44
| Open | 2.26 | Prev Close | 2.27 | Low | 2.25 | High | 2.28 | Mkt Cap | 69.51M |
| Vol | 17.91K | Avg Vol | 34.05K | EPS | -1.48 | P/E | N/A | Forward P/E | 34.62 |
| Beta | 0.84 | Short Ratio | 15.03 | Inst. Own | 16.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 07-15 | Earning | 08-15 | 50-d Avg | 2.30 | 200-d Avg | 2.40 | 1yr Est | 13.00 |
| Income Statement | |||
| Operating Expenses | 6.15M | ||
| Research and Development Expense | 5.30M | ||
| Selling, General and Administrative Expense | 850.00K | ||
| Operating Income | -6.15M | ||
| Income Tax Expense | 46.00K | ||
| Net Income | -6.73M | ||
| Net Income Common Stock | -6.73M | ||
| Net Income Common Stock (USD) | -6.73M | ||
| Consolidated Income | -6.73M | ||
| Earnings per Basic Share | -0.22 | ||
| Earnings per Basic Share (USD) | -0.22 | ||
| Earnings per Diluted Share | -0.22 | ||
| Earning Before Interest & Taxes (EBIT) | -6.68M | ||
| Earning Before Interest & Taxes (USD) | -6.68M | ||
| Weighted Average Shares | 30.49M | ||
| Weighted Average Shares Diluted | 30.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 109.53M | ||
| Cash and Equivalents (USD) | 109.53M | ||
| Current Assets | 111.16M | ||
| Property, Plant & Equipment Net | 22.49M | ||
| Total Assets | 133.65M | ||
| Current Liabilities | 3.35M | ||
| Total Liabilities | 5.19M | ||
| Accumulated Retained Earnings (Deficit) | -148.61M | ||
| Shareholders Equity | 128.46M | ||
| Shareholders Equity (USD) | 128.46M | ||
| Assets Non-Current | 22.49M | ||
| Liabilities Non-Current | 1.84M | ||
| Trade and Non-Trade Payables | 1.11M | ||
| Tax Assets | 14.00K | ||
| Tax Liabilities | 1.84M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 302.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.93M | ||
| Capital Expenditure | -4.00K | ||
| Net Cash Flow from Investing | -4.00K | ||
| Net Cash Flow from Operations | -4.51M | ||
| Effect of Exchange Rate Changes on Cash | -1.41M | ||
| Share Based Compensation | 172.00K | ||